Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7310)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2015 (publication date) through May 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mao ZY, Zhu GQ, Xiong M, Ren L, Bai L. Prognostic value of neutrophil distribution in cholangiocarcinoma. World J Gastroenterol 2015; 21(16): 4961-4968 [PMID: 25945010 DOI: 10.3748/wjg.v21.i16.4961] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i16/4961.htm |
| Number | Citing Articles |
| 1 |
Luca Fabris, María J. Perugorria, Joachim Mertens, Niklas K. Björkström, Thorsten Cramer, Ana Lleo, Antonio Solinas, Hanna Sänger, Veronika Lukacs‐Kornek, Anja Moncsek, Alexander Siebenhüner, Mario Strazzabosco. The tumour microenvironment and immune milieu of cholangiocarcinoma. Liver International 2019; 39(S1): 63 doi: 10.1111/liv.14098
|
| 2 |
Carolina Liguori, Cecilia Copparoni, Cristiano Felicetti, Federica Pecci, Alessio Lupi, Giada Pinterpe, Rossana Berardi, Riccardo Giampieri. Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study. Current Oncology 2023; 30(1): 1032 doi: 10.3390/curroncol30010079
|
| 3 |
Siqi Yang, Ruiqi Zou, Yushi Dai, Yafei Hu, Fuyu Li, Haijie Hu. Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review). International Journal of Oncology 2023; 63(6) doi: 10.3892/ijo.2023.5585
|
| 4 |
Toshihiko Yusa, Yo‐ichi Yamashita, Hirohisa Okabe, Yosuke Nakao, Rumi Itoyama, Yuki Kitano, Takayoshi Kaida, Tatsunori Miyata, Kosuke Mima, Katsunori Imai, Hiromitsu Hayashi, Hideo Baba. Survival impact of immune cells infiltrating peritumoral area of hepatocellular carcinoma. Cancer Science 2022; 113(12): 4048 doi: 10.1111/cas.15437
|
| 5 |
Francesca Vita, Irene Olaizola, Francesco Amato, Colin Rae, Sergi Marco, Jesus M. Banales, Chiara Braconi. Heterogeneity of Cholangiocarcinoma Immune Biology. Cells 2023; 12(6): 846 doi: 10.3390/cells12060846
|
| 6 |
Lavinia Patricia Mocan, Rares Craciun, Cristiana Grapa, Carmen Stanca Melincovici, Ioana Rusu, Nadim Al Hajjar, Zeno Sparchez, Daniel Leucuta, Maria Ilies, Mihaela Sparchez, Tudor Mocan, Carmen Mihaela Mihu. PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for patients with intrahepatic cholangiocarcinoma. Cancer Immunology, Immunotherapy 2023; 72(4): 1003 doi: 10.1007/s00262-022-03309-y
|
| 7 |
Sophia Kästle, Matthias R. Stechele, Lisa Richter, Regina Schinner, Elif Öcal, Marianna Alunni-Fabbroni, Enrico De Toni, Stefanie Corradini, Max Seidensticker, S. Nahum Goldberg, Jens Ricke, Moritz Wildgruber, Melanie A. Kimm. Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(12): 9777 doi: 10.1007/s00432-023-04875-z
|
| 8 |
Alphonse E. Sirica, Mario Strazzabosco, Massimiliano Cadamuro. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 321 doi: 10.1016/bs.acr.2020.10.005
|
| 9 |
Ronen Sumagin. Phenotypic and Functional Diversity of Neutrophils in Gut Inflammation and Cancer. The American Journal of Pathology 2024; 194(1): 2 doi: 10.1016/j.ajpath.2023.10.009
|
| 10 |
Vinit Kumar, Laxminarasimha Donthireddy, Douglas Marvel, Thomas Condamine, Fang Wang, Sergio Lavilla-Alonso, Ayumi Hashimoto, Prashanthi Vonteddu, Reeti Behera, Marlee A. Goins, Charles Mulligan, Brian Nam, Neil Hockstein, Fred Denstman, Shanti Shakamuri, David W. Speicher, Ashani T. Weeraratna, Timothy Chao, Robert H. Vonderheide, Lucia R. Languino, Peter Ordentlich, Qin Liu, Xiaowei Xu, Albert Lo, Ellen Puré, Chunsheng Zhang, Andrey Loboda, Manuel A. Sepulveda, Linda A. Snyder, Dmitry I. Gabrilovich. Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors. Cancer Cell 2017; 32(5): 654 doi: 10.1016/j.ccell.2017.10.005
|
| 11 |
Oraianthi Fiste, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Michalis Liontos, Konstantinos Koutsoukos, Meletios Athanasios Dimopoulos, Flora Zagouri. The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma. Vaccines 2021; 9(5): 422 doi: 10.3390/vaccines9050422
|
| 12 |
Lorenza Rimassa, Nicola Personeni, Alessio Aghemo, Ana Lleo. The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine. Journal of Autoimmunity 2019; 100: 17 doi: 10.1016/j.jaut.2019.03.007
|
| 13 |
Riccardo Carloni, Alessandro Rizzo, Angela Dalia Ricci, Alessandro Di Federico, Raffaele De Luca, Deniz Can Guven, Suayib Yalcin, Giovanni Brandi. Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine. Translational Oncology 2022; 25: 101514 doi: 10.1016/j.tranon.2022.101514
|
| 14 |
Rocio I R Macias, Vincenzo Cardinale, Timothy J Kendall, Matias A Avila, Maria Guido, Cedric Coulouarn, Chiara Braconi, Adam E Frampton, John Bridgewater, Diletta Overi, Stephen P Pereira, Marco Rengo, Jakob N Kather, Angela Lamarca, Federica Pedica, Alejandro Forner, Juan W Valle, Eugenio Gaudio, Domenico Alvaro, Jesus M Banales, Guido Carpino. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions. Gut 2022; : gutjnl-2022-327099 doi: 10.1136/gutjnl-2022-327099
|
| 15 |
Michela Anna Polidoro, Joanna Mikulak, Valentina Cazzetta, Ana Lleo, Domenico Mavilio, Guido Torzilli, Matteo Donadon. Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells. World Journal of Gastroenterology 2020; 26(33): 4900-4918 doi: 10.3748/wjg.v26.i33.4900
|
| 16 |
Chunbin Zhu, Jiaqiang Ma, Kai Zhu, Lei Yu, Bohao Zheng, Dongning Rao, Shu Zhang, Liangqing Dong, Qiang Gao, Xiaoming Zhang, Diyang Xie. Spatial immunophenotypes predict clinical outcome in intrahepatic cholangiocarcinoma. JHEP Reports 2023; 5(8): 100762 doi: 10.1016/j.jhepr.2023.100762
|
| 17 |
Emilien Loeuillard, Caitlin B. Conboy, Gregory J. Gores, Sumera Rizvi. Immunobiology of cholangiocarcinoma. JHEP Reports 2019; 1(4): 297 doi: 10.1016/j.jhepr.2019.06.003
|
| 18 |
Pedro M. Rodrigues, Paula Olaizola, Nuno A. Paiva, Irene Olaizola, Alona Agirre-Lizaso, Ana Landa, Luis Bujanda, Maria J. Perugorria, Jesus M. Banales. Pathogenesis of Cholangiocarcinoma. Annual Review of Pathology: Mechanisms of Disease 2021; 16(1): 433 doi: 10.1146/annurev-pathol-030220-020455
|
| 19 |
Tim F. Greten, Robert Schwabe, Nabeel Bardeesy, Lichun Ma, Lipika Goyal, Robin K. Kelley, Xin W. Wang. Immunology and immunotherapy of cholangiocarcinoma. Nature Reviews Gastroenterology & Hepatology 2023; 20(6): 349 doi: 10.1038/s41575-022-00741-4
|
| 20 |
Shuochen Liu, Shilong Fan, Yirui Wang, Ruixiang Chen, Ziyi Wang, Yaodong Zhang, Wangjie Jiang, Yananlan Chen, Xiao Xu, Yue Yu, Changxian Li, Xiangcheng Li. ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10903-5
|
| 21 |
Ines Malenica, Matteo Donadon, Ana Lleo. Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine. Cancers 2020; 12(8): 2190 doi: 10.3390/cancers12082190
|
| 22 |
Hu Liu, Guoteng Qiu, Fengjuan Hu, Hong Wu. Fibrinogen/albumin ratio index is an independent predictor of recurrence-free survival in patients with intrahepatic cholangiocarcinoma following surgical resection. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02330-2
|
| 23 |
Juliette Paillet, Guido Kroemer, Jonathan G. Pol. Immune contexture of cholangiocarcinoma. Current Opinion in Gastroenterology 2020; 36(2): 70 doi: 10.1097/MOG.0000000000000613
|
| 24 |
Xianzhe Yu, Lingling Zhu, Ting Wang, Jiang Chen. Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1037945
|
| 25 |
Chiara Raggi, Margherita Correnti, Antonio Sica, Jesper B. Andersen, Vincenzo Cardinale, Domenico Alvaro, Giovanna Chiorino, Elisa Forti, Shannon Glaser, Gianfranco Alpini, Annarita Destro, Francesca Sozio, Luca Di Tommaso, Massimo Roncalli, Jesus M. Banales, Cédric Coulouarn, Luis Bujanda, Guido Torzilli, Pietro Invernizzi. Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages. Journal of Hepatology 2017; 66(1): 102 doi: 10.1016/j.jhep.2016.08.012
|
| 26 |
Kangkang Liu, Kun Zhao, Lining Wang, Erlin Sun. The prognostic values of tumor-infiltrating neutrophils, lymphocytes and neutrophil/lymphocyte rates in bladder urothelial cancer. Pathology - Research and Practice 2018; 214(8): 1074 doi: 10.1016/j.prp.2018.05.010
|
| 27 |
Kim C. Ohaegbulam, Yilun Koethe, Alice Fung, Skye C. Mayo, Aaron J. Grossberg, Emerson Y. Chen, Kaveh Sharzehi, Adel Kardosh, Khashayar Farsad, Flavio G. Rocha, Charles R. Thomas, Nima Nabavizadeh. The multidisciplinary management of cholangiocarcinoma. Cancer 2023; 129(2): 184 doi: 10.1002/cncr.34541
|
| 28 |
Vittorio Branchi, Benedict Jürgensen, Laura Esser, Maria Gonzalez-Carmona, Tobias J. Weismüller, Christian P. Strassburg, Jonas Henn, Alexander Semaan, Philipp Lingohr, Steffen Manekeller, Glen Kristiansen, Jörg C. Kalff, Marieta I. Toma, Hanno Matthaei. Tumor Infiltrating Neutrophils Are Frequently Found in Adenocarcinomas of the Biliary Tract and Their Precursor Lesions with Possible Impact on Prognosis. Journal of Personalized Medicine 2021; 11(3): 233 doi: 10.3390/jpm11030233
|
| 29 |
Luca Fabris, Keisaku Sato, Gianfranco Alpini, Mario Strazzabosco. The Tumor Microenvironment in Cholangiocarcinoma Progression. Hepatology 2021; 73(S1): 75 doi: 10.1002/hep.31410
|